QGEN Qiagen N.V.
Qiagen N.V. (QGEN) is expected to report earnings on November 4, 2026, after the market close. The consensus earnings estimate is $0.62 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +1.3% since its last earnings release on August 5, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Qiagen N.V.
Qiagen NV provides sample and assay technologies. It also offers kits, assays, related automated systems and bioinformatics solutions, that cover the entire continuum from basic life sciences research to clinical diagnostics.
Sector
Healthcare
Industry
Diagnostic Substances